文献速递肿瘤 PET/CT甲状腺核医学

嗜铬细胞瘤的定量18F-DOPA PET/CT:肿瘤分泌与生化表型的关系

Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-09-16

回顾性纳入56例非转移性嗜铬细胞瘤患者,评估18F-DOPA PET/CT代谢参数与尿甲氧基肾上腺素及血浆嗜铬粒蛋白A的相关性,发现总病灶摄取与尿甲氧基肾上腺素相关性最强,提示18F-DOPA PET可在定位之外提供肿瘤生化表型信息。

要点

  • 56例非转移性嗜铬细胞瘤患者18F-DOPA PET/CT均阳性。
  • 总病灶摄取与尿甲氧基肾上腺素相关性最强(p=8.10-15,r=0.80)。
  • 多因素分析中摄取参数与血浆嗜铬粒蛋白A的相关性不再持续。

核心结论

  • 本回顾性研究显示18F-DOPA摄取(尤其总病灶摄取)与尿甲氧基肾上腺素及嗜铬细胞瘤生化表型相关。
  • 18F-DOPA PET除定位价值外,还可从特定代谢层面实现嗜铬细胞瘤表征。

研究设计与样本

  • 回顾性研究,纳入56例经18F-DOPA PET/CT评估的非转移性嗜铬细胞瘤患者,女性占56%,中位年龄47.5岁。
  • 45例(80.4%)基因检测阴性;5例(8.9%)RET突变,2例(3.6%)SDHB突变,2例(3.6%)SDHD突变,1例(1.8%)NF1突变,1例(1.8%)VHL突变。
  • 评估18F-DOPA代谢参数(肿瘤SUVmax、肿瘤SUVmean、肿瘤SUVmax/肝SUVmax、MTV 42%、总病灶摄取)与尿甲氧基肾上腺素及血浆嗜铬粒蛋白A的相关性。

主要发现

  • 所有患者18F-DOPA PET/CT均为阳性。
  • 单因素分析显示所有代谢参数与尿甲氧基肾上腺素及血浆嗜铬粒蛋白A均强相关。
  • 总病灶摄取与尿甲氧基肾上腺素相关性最高(p=8.10-15,r=0.80),MTV 42%与血浆嗜铬粒蛋白A相关性最高(p=2.10-9,r=0.74)。
  • 多因素分析中,摄取参数与血浆嗜铬粒蛋白A的相关性不再持续,归因于嗜铬粒蛋白A与肿瘤直径的关系。
  • 总病灶摄取与去甲氧基肾上腺素/甲氧基肾上腺素比值(NMN/MN)存在相关性,与体外研究一致,即产肾上腺素嗜铬细胞瘤儿茶酚胺含量更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: 18F-FDOPA illustrates the properties of uptake and storage of catecholamines in pheochromocytomas (PHEOs). Until now, the relationship between 18F-FDOPA quantitative parameters and a PHEO secretory profile has not been specifically evaluated. MATERIALS AND METHODS: Fifty-six patients (56% females, median age: 47.5 yrs) with non-metastatic PHEO, evaluated by 18F-FDOPA PET/CT, were included in this retrospective study. Forty-five patients had negative genetic testing (80.4%); five patients (8.9%) had RET, two patients (3.6%) had SDHB, two had SDHD (3.6%), one patient (1.8%) had NF1, and one patient had a VHL (1.8%) mutation. Correlation between 18F-FDOPA metabolic parameters (tumor SUVmax, tumor SUVmean, tumor SUVmax/liver SUVmax, MTV 42%, total lesion uptake), urinary metanephrines (MNs), and plasma chromogranin A (CgA) were evaluated. RESULTS: All patients had positive 18F-FDOPA PET/CT. On univariate analysis, there was a strong correlation between all metabolic parameters and urinary MNs and plasma chromogranin A (CgA). The highest correlations were observed between total lesion (TL) uptake and the value of urinary MNs regardless of their nature (p = 8.10-15 and r = 0.80) and between MTV 42% and plasma CgA levels (p = 2.10-9, r = 0.74). On multivariate analysis, the correlation of uptake parameters and CgA levels did not persist further due to the relation of CgA and tumor diameter. A correlation between TL uptake and the normetanephrine/metanephrine ratio (NMN/MN) was also found, a finding that was in accordance with in vitro studies, which were found to have a higher catecholamine content in epinephrine producing PHEOs. CONCLUSION: This retrospective study shows a correlation between 18F-FDOPA uptake, especially using TL uptake, urinary MNs, and a PHEO biochemical phenotype. This illustrates that beyond its localization value, 18F-FDOPA PET further enables PHEO characterization at a specific metabolic level.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Amodru V, Guerin C, Delcourt S, et al. Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype. Eur J Nucl Med Mol Imaging. 2017. PMID: 28918451. doi:10.1007/s00259-017-3833-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。